These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 45088)

  • 61. [Clinical results of cefaclor treatment of infections of oral regions].
    Yoshida Y; Kita T; Kanematsu N; Sato K; Kawata K; Fukuta N; Sato J
    Jpn J Antibiot; 1984 Mar; 37(3):318-28. PubMed ID: 6737694
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [A simple disk diffusion test to identify beta-lactamase-negative, ampicillin-resistant Haemophilus influenzae--application of cephalexin, cefsulodin and cefaclor disks].
    Endo R; Yamane N; Tamayose MH; Uchibori KK; Nakasone I
    Rinsho Byori; 2010 Oct; 58(10):963-71. PubMed ID: 21077285
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative efficacies of erythromycin-sulfisoxazole and cefaclor in acute otitis media: a double blind randomized trial.
    Bergeron MG; Ahronheim G; Richard JE; Riding K; Cron C; Bryer D; Macdonald N; Bouchard M; Young J; Dempsey EE
    Pediatr Infect Dis J; 1987 Jul; 6(7):654-60. PubMed ID: 3302918
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antimicrobial activities and susceptibility testing considerations of ampicillin, cephalothin, cefaclor, and cefuroxime against invasive isolates of Haemophilus influenzae.
    Shelton MM; Welch DF
    Chemotherapy; 1989; 35(2):88-94. PubMed ID: 2788068
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vitro susceptibility of selected bacteria to cefaclor.
    Valenti AJ; Andriole VT
    Yale J Biol Med; 1977; 50(5):465-9. PubMed ID: 341537
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bowel flora changes in humans receiving cefixime (CL 284,635) or cefaclor.
    Finegold SM; Ingram-Drake L; Gee R; Reinhardt J; Edelstein MA; MacDonald K; Wexler H
    Antimicrob Agents Chemother; 1987 Mar; 31(3):443-6. PubMed ID: 3579262
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Stability in the presence of widespread beta-lactamases. A prerequisite for the antibacterial activity of beta-lactam drugs.
    Schito GC; Pesce A; Debbia EA
    Drugs; 1994; 47 Suppl 3():1-8; discussion 8-9. PubMed ID: 7518761
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical advances in oral antibiotic therapy. Summary and closing remarks.
    Neu HC
    Postgrad Med J; 1979; 55 Suppl 4():100-1. PubMed ID: 548938
    [No Abstract]   [Full Text] [Related]  

  • 70. Cefaclor: a contemporary look at susceptibility of key pathogens from around the globe.
    Preston DA; Turik M
    J Chemother; 1998 Jun; 10(3):195-202. PubMed ID: 9669643
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cefaclor levels in human aqueous humor.
    Axelrod JL; Kochman RS
    Arch Ophthalmol; 1980 Apr; 98(4):740-2. PubMed ID: 7369913
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Influence of amoxycillin and cefaclor on the colonization resistance of oropharynx.
    van Saene HK; Willems FT; Zweens J
    Scand J Infect Dis Suppl; 1983; 39():97-9. PubMed ID: 6359384
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [The antibacterial efficacy of cefaclor against bacteria resistant to ampicillin, tetracycline and co-trimoxazole (author's transl)].
    Machka K
    Infection; 1979; 7 Suppl 6():536-9. PubMed ID: 399244
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antimicrobial activity in vitro of cefaclor, a new oral cephalosporin.
    Meyers BR; Hirschman SZ
    J Clin Pharmacol; 1978; 18(2-3):85-90. PubMed ID: 624778
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxil.
    Angehrn P; Hohl P; Then RL
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):536-43. PubMed ID: 2504597
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 3-trifluoromethylcarbacephems: synthesis of broad spectrum antibacterial compounds.
    Cook GK; Hornback WJ; McDonald JH; Munroe JE; Snyder NJ
    Bioorg Med Chem Lett; 1998 May; 8(10):1261-6. PubMed ID: 9871746
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In vitro antibacterial activity of cefixime.
    Lin SR; Peng CF
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1988 Oct; 4(10):586-91. PubMed ID: 3230604
    [No Abstract]   [Full Text] [Related]  

  • 78. Treatment of otitis media with cefaclor, a new oral cephalosporin.
    Aronovitz GH
    South Med J; 1980 Nov; 73(11):1447-9. PubMed ID: 6969442
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A pharmacological and in vitro comparison of three oral cephalosporins.
    Wise R; Andrews JM; Dean S; Welling PG; Kendall MJ
    J Antimicrob Chemother; 1979 Sep; 5(5):601-7. PubMed ID: 115833
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparative antibacterial activity of the new cephalosporin cefcanel against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):550-1. PubMed ID: 2548866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.